GAM
TXG icon

Gotham Asset Management’s 10x Genomics TXG Stock Holding History

Gotham Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.24M Sell
110,660
-4,293
-4% -$113K 0.01% 982
2026
Q1 		$2.44M Buy
114,953
+20,236
+21% +$405K 0.01% 1051
2025
Q4 		$1.54M Buy
94,717
+75,785
+400% +$1.14M 0.01% 1123
2025
Q3 		$221K Sell
18,932
-57,606
-75% -$751K ﹤0.01% 1593
2025
Q2 		$886K Buy
+76,538
New +$698K 0.01% 1174
2025
Q1 		– Sell
-18,389
Closed -$264K – 1664
2024
Q4 		$264K Buy
+18,389
New +$290K ﹤0.01% 1300
2024
Q1 		– Sell
-8,686
Closed -$486K – 1467
2023
Q4 		$486K Buy
8,686
+1,667
+24% +$72.5K 0.01% 999
2023
Q3 		$290K Buy
7,019
+114
+2% +$5.93K 0.01% 1129
2023
Q2 		$386K Buy
6,905
+1,881
+37% +$102K 0.01% 1049
2023
Q1 		$280K Buy
+5,024
New +$235K 0.01% 1153

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Gotham Asset Management's TXG Position: Q2 2026 in Review

Gotham Asset Management reduced its 10x Genomics (TXG) stake by 3.7% in Q2 2026, selling an estimated $113K and leaving 110,660 shares worth $4.24M. The position accounts for 0.01% of the portfolio, ranked #982.

Gotham Asset Management first reported a position in TXG in Q1 2023 and has held it in 10 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Gotham Asset Management held 110,660 shares of 10x Genomics worth $4.24M as of Q2 2026.
  • Gotham Asset Management sold 4,293 10x Genomics shares in Q2 2026, an estimated $113K.
  • 10x Genomics made up 0.01% of Gotham Asset Management's portfolio in Q2 2026, its #982 holding.
  • Gotham Asset Management first reported a position in 10x Genomics in Q1 2023 and has held it in 10 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.